{
  "id": 16232340,
  "title": "Supplement Shows Promise for Improving Cancer-Related Cognitive Impairment",
  "url": "https://urgent.news/2026/10/23/supplement-shows-promise-for-improving-cancer-related-cognitive",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-23T20:45:19.000Z",
  "source": {
    "name": "MedPage Today",
    "slug": "medpage-today",
    "url": "https://www.medpagetoday.com/hematologyoncology/breastcancer/123559"
  },
  "original_language": "en",
  "account": null,
  "summary": "(MedPage Today) -- Cancer-related cognitive impairment (CRCI) in breast cancer survivors improved significantly after treatment with the glutamate regulator oxaloacetate, a preliminary single-arm clinical study showed. All 16 evaluable patients...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}